Childhood Malignant Neoplasm — Trials

Childhood Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,178 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 263
Recruiting: 158
Ph III recruiting: 9
Growth YoY: −7.4%
Industry share: 8%
Top sponsor: St. Jude Children's Research Hospital
Termination share: 19.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (92)

clinicaltrialsPublishedShowing 1,151–1,178 of 1,178 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00042796	Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia	terminated	Phase 1	21	National Cancer Institute (NCI)NIH	1	Jan 23, 2013	clinicaltrials
NCT00054431	Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia	completed	Phase 2	80	National Cancer Institute (NCI)NIH	1	Jan 23, 2013	clinicaltrials